News

Merck & Co., Inc.'s 4.09% dividend yield and robust pipeline signal strong growth potential. Click here to read an analysis ...
Merck gets lift from U.S. patent office in battle over injectable form of Keytruda Dispute with Halozyme Therapeutics could affect plans to extend its franchise product Adobe By Ed Silverman June ...
By Colin Kellaher Merck & Co. and Daiichi Sankyo have pulled an application seeking accelerated Food and Drug Administration approval of one of the drug candidates in their multibillion-dollar ...
A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated based on historical and future fair values. Alphabet's strong financials, attractive historical valuations, and ...
One chart shows why Ireland could be among hardest hit by Trump's tariffs business Ireland is among countries vulnerable to changes in the global economy proposed by Donald Trump Share this article ...
Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health and Human Services ...
Gintaras V. (Rex) Reklaitis, the Burton and Kathryn Gedge Distinguished Professor of Chemical Engineering and a member of the Young Institute, works on pharmaceutical manufacturing equipment in Purdue ...
WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...
Merck’s shares have lost 15.3% in the past year compared witha decline of 3.9% for the industry. The stock has also underperformed the sector and the S&P 500 Index, as seen in the chart below.
On that last point, Merck has increased its payout by a decent 71% in the past five years and offers a dividend yield of 2.8% currently, which is above the S&P 500's average of 1.3%.
Posted: July 30, 2024 | Last updated: July 30, 2024 Merck is down 10% today. The Investment Committee discuss the biotech sector. More for You ...